Frankfurt-am-Main, Germany

Peter Florian


 

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Peter Florian in Antibody Development

Introduction

Peter Florian is an accomplished inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. With a total of two patents to his name, Florian's work focuses on advancing medical treatments for vascular diseases.

Latest Patents

Florian's latest patents include innovative antagonist antibodies and their Fab fragments against Glycoprotein VI (GPVI). These antibodies specifically bind to the human platelet membrane protein GPVI and include monovalent fragments or derivatives. The antibodies derived from hybridoma clone 390 are capable of inducing a GPVI depletion phenotype. They effectively block collagen binding, thereby preventing platelet activation by collagen. The patents also encompass hybridoma clones and expression plasmids for producing these antibodies and Fab fragments. Furthermore, the inventions detail the use of monovalent antibody fragments in creating research, diagnostic, and immunotherapeutic agents for treating thrombosis and other vascular diseases. Notably, the patents describe methods for preventing platelet activation when an anti-GP VI Fab is utilized.

Career Highlights

Peter Florian is currently employed at Sanofi, a leading global biopharmaceutical company. His work at Sanofi has allowed him to focus on innovative research and development in the field of antibody therapies. Florian's expertise in biotechnology has positioned him as a key player in advancing therapeutic solutions for complex medical conditions.

Collaborations

Florian collaborates with notable colleagues, including Nicolas Baurin and Francis Blanche. Their combined efforts contribute to the ongoing research and development of groundbreaking medical treatments.

Conclusion

Peter Florian's contributions to the field of antibody development are noteworthy and impactful. His innovative patents and work at Sanofi highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…